Can a new biopsy needle unlock personalized pancreatic cancer therapy?
NCT ID NCT05249075
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This trial evaluates a new biopsy needle (Micro-Tech FNB) used during endoscopic ultrasound to collect tissue samples from suspected pancreatic tumors. The goal is to see if this needle provides accurate diagnoses and yields enough high-quality tissue for genetic sequencing, which could guide personalized chemotherapy. Adults with suspected pancreatic adenocarcinoma who need a biopsy are eligible to participate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Micro-Tech FNB needle (a fine needle biopsy device used during endoscopic ultrasound to obtain tissue samples from pancreatic tumors)
- What this could lead to
- If successful, this needle could improve the accuracy of pancreatic cancer diagnosis and provide better tissue samples for genetic testing, potentially enabling more personalized chemotherapy.
- What could go wrong
- This is a relatively early study, and the new needle may not prove superior to existing ones. There are also standard risks associated with endoscopic ultrasound procedures, such as bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radboudumc
Nijmegen, Gelderland, 6525 GA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can new tracers make many cancers light up on scans?
- A card game could open the door to better End-of-Life conversations
- Can a Triple-Drug combo outsmart advanced pancreatic cancer?
- Smartwatch-Guided prehab aims to boost pancreatic surgery recovery
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early